MycoBiomDB – Record Details (MyCo_1424)

Biomarker Record Details

Database ID: MyCo_1424
DB IDMyCo_1424
TitleImpact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa
Year2021
PMID33399865
Fungal Diseases involvedCryptococcal meningitis
Associated Medical ConditionHIV-AIDS
GenusCryptococcus
Speciesspp.
OrganismCryptococcus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceCerebrospinal fluid (CSF)
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIL-10
Biomarker Full NameInterleukin-10
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUganda and South Africa
CohortWe analyzed prospectively screened participants’ data from the Cryptococcal Optimal ART Timing trial (n = 226) (Clinical- Trials.gov: NCT01075152), Neurological Outcomes on ART study (n = 26), and the Adjunctive Sertraline for the Treat- ment of HIV-Associated Cryptococcal Meningitis pilot phase and trial (n = 725) (ClinicalTrials.gov: NCT01802385).
Cohort No.977
Age Group32-36
P Valuep<.05
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismCryptococcal meningitis remains the second leading cause of mortality among HIV-infected persons. The greatest burden of cryptococcal meningitis is in sub-Saharan Africa where an esti- mated 73% of incident cases and 75% deaths occur. Despite this, important patient demographic information, such as bio- logical sex, is limited in sub-Saharan Africa. There have been at least five studies to evaluate biological sex in cryptococcal meningitis cohorts. Of these,four cohorts reported higher in- cidence of cryptococcal meningitis in men compared to women, but only two of these studies were from Africa. Mortalitydueto cryptococcal meningitis is not often reported by biological sex. However, one study based in China indicated that women had a slightly higher mortality of cryptococcal meningitis in their cohort.
TechniqueAnalytic
Analysis MethodCox proportional hazards models analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedCox proportional hazards models analysis
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone